ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ESMO 2021 Update on the Efficacy and Safety of [Vic-]Trastuzumab Duocarmazine vs. TPC in HER2+ MBC: Primary Outcomes of the TULIP Study
By
ecancer
FEATURING
Cristina Saura
By
ecancer
FEATURING
Cristina Saura
Login to view comments.
Click here to Login
